Page last updated: 2024-10-20

selenious acid and Neuronal Ceroid-Lipofuscinoses

selenious acid has been researched along with Neuronal Ceroid-Lipofuscinoses in 2 studies

Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.

Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naidu, S1
Maumanee, I1
Olson, J1
Borel, J1
Moser, H1
Santavuori, P1
Westermarck, T1
Rapola, J1
Pohja, P1
Moren, R1
Lappi, M1
Vuonnala, U1

Other Studies

2 other studies available for selenious acid and Neuronal Ceroid-Lipofuscinoses

ArticleYear
Selenium treatment in neuronal ceroid-lipofuscinosis.
    American journal of medical genetics. Supplement, 1988, Volume: 5

    Topics: Child; Child, Preschool; Drug Therapy, Combination; Erythrocytes; Follow-Up Studies; Glutathione Per

1988
Antioxidant treatment in Spielmeyer-Sjögren's disease.
    Acta neurologica Scandinavica, 1985, Volume: 71, Issue:2

    Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Child; Drug Therapy, Combi

1985